Tatva Chintan Pharma Chem Ltd

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 31 March 2023 issued by ICICI Bank Limited appointed to monitor the utilization of proceeds of an Initial Public Offering (IPO) of the Company. The above information shall be made available on the website of the Company at www.tatvachintan.com.